Feb 22, 2022 / 12:00AM GMT
Operator
Thank you for standing by, and welcome to the SomnoMed 2022 Half Year Results Call. (Operator Instructions)
I would like to now hand over the conference to Neil Verdal-Austin, CEO. Please go ahead, Neil.
Neil Verdal-Austin - SomnoMed Limited - Global CEO, MD & Director
Thank you, Lisa. Well, good morning, ladies and gentlemen. And as mentioned, my name is Neil Verdal-Austin, and I'm the CEO of SomnoMed Limited. Thank you for joining us for this audio webcast where we present our half year '22 results and elaborate further on the new technology recently announced.
The disclaimer and agenda slides are self-explanatory, so let's start with Slide 5, the half year financial highlights. We are extremely pleased with the revenue growth seen in the North American region, while in Europe, this growth was softened by the various COVID restrictions, limiting our access to physicians and hospitals, while patients also postponed their dental appointments due to the COVID pandemic.
In APAC, we experienced the same due to the
Half Year 2022 Somnomed Ltd Earnings Call Transcript
Feb 22, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers